51817-586-01 : NDC 2026 Code

51817-586-01 : Bortezomib ( Bortezomib )

Additionally :

You can get information about “51817-586-01” NDC code in 51817-586-01 in HTML format

HTML | 51817-586-01 in TXT (Plain Text) format

TXT | 51817-586-01 in PDF (Portable Document Format)

PDF | 51817-586-01 in XML format

XML formats.

NDC Code : 51817-586-01 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "51817-586-01",
    "PackageDescription": "1 VIAL in 1 CARTON (51817-586-01)  &gt; 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL",
    "NDC11Code": "51817-0586-01",
    "ProductNDC": "51817-586",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Bortezomib",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Bortezomib",
    "DosageFormName": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
    "RouteName": "INTRAVENOUS; SUBCUTANEOUS",
    "StartMarketingDate": "20220502",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA208392",
    "LabelerName": "Pharmascience Inc.",
    "SubstanceName": "BORTEZOMIB",
    "StrengthNumber": "3.5",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2022-05-06",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20220502",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}